The cysteine protease cathepsin L exhibits hormone-regulated expression during ovulation. In situ hybridization analyses of immature and pregnant mare serum gonadotropintreated mouse and rat ovaries showed that cathepsin L expression in granulosa cells of small, growing follicles increased in periovulatory follicles after human chorionic gonadotropin stimulation. In the rat ovary, cathepsin L was also expressed in follicles with signs of atresia. To determine the molecular mechanisms that mediate the diverse regulation of this gene in granulosa cells, rat cathepsin L promoter-reporter constructs were analyzed by transient transfection assays in rat granulosa cells and EMSAs. A construct containing the transcriptional start site and ؊244 bp of upstream promoter sequence (؊244/؉33 bp) exhibited inducibility by forskolin, the phorbol ester phorbol myristate acetate, and an additive effect of both. Within this region, three functional specificity protein 1 (Sp1) sites, an overlapping early growth 
C ATHEPSIN L IS A lysosomal cysteine protease that
belongs to the papain family of enzymes (1) . However, in certain endocrine cells like Sertoli cells of the testis and placental trophoblasts as well as certain tumors, cathepsin L is secreted (2) , indicating that this protease functions at both intracellular and extracellular sites. There is also increasing evidence that cathepsins secreted by macrophages, osteoclasts, fibroblasts, and transformed cells exert functions that impact angiogenesis and tumor progression (3) (4) . Recently, cathepsin L has been identified as an IL-8 convertase (5) and thus may be important in the migration of immune cells.
In the ovary, cathepsin L is expressed in granulosa cells of follicles at different stages of growth (6) , suggesting that this protease may play diverse roles in this tissue. During ovulation, a process that resembles an inflammatory reaction, cathepsin L (along with other proteases) may impact the extensive remodeling of the extracellular matrix that occurs before follicle rupture. Specifically, because cathepsin L is activated when complexed with glycosaminaglycans, such as those present in the follicular fluid, and because it can degrade collagen (I and IV), elastin, and fibronectin, it is highly likely that cathepsin L is a modifier of extracellular matrices in preovulatory follicles (7) . In addition, cathepsin L may play a role in apoptosis or in recruiting immune cells.
The expression of cathepsin L appears to be regulated by many factors. In NIH3T3 cells, the cathepsin L gene is activated by platelet-derived growth factor, epidermal growth factor, and cAMP and inhibited by TGF-␤ (2). In the ovary, cathepsin L is expressed in the granulosa cells of preovulatory follicles after the surge of LH, and this response is altered in follicles of progesterone receptor (PR) null mice (PRKO) that fail to ovulate (6, 8, 9) . Cathepsin L expression is also regulated by progesterone in the cat uterus where high levels of the protease are secreted by the endometrium (10) . However, a functional link between PR and the expression of cathepsin L in either the ovary or the uterus has not been fully documented. Thus, analyses of the hormones and molecular mechanisms by which this protease is induced in the ovary are highly relevant to our understanding of several endocrine functions, including ovulation.
The 5Ј-flanking region of the rat cathepsin L gene has been cloned recently (11) . Like the mouse and human, the 5Ј-upstream region of this gene lacks the classical TATA-binding motif (12) . Although the absence of a TATA box might indicate that cathepsin L belongs to a class of housekeeping genes, this description is too simplistic because cathepsin L is regulated by a diverse set of hormones and growth regulatory molecules in many different cell types. Moreover, the expression of cathepsin L is increased in ovulatory follicles of wild-type mice and misregulated in mice null for PR (5) . However, because the message for this protease is also present in small follicles, PR is not the only regulator of cathepsin L expression in the granulosa cells of the rodent ovary. Recent studies using reporter constructs of cathepsin L in Sertoli cells demonstrated that a 120-bp region (Ϫ87/ ϩ33) that spans the transcription start site is sufficient to activate basal transcription in Sertoli cells isolated from sexually mature rats (13) . A GC box in this region binds specificity protein 3 (Sp3), but not specificity protein 1 (Sp1) in Sertoli cell nuclear extracts, and is critical for transactivation of this gene in Sertoli cells (13) . Studies with 3Y1 cells suggested that Sp1 could regulate the transcription of the cathepsin L gene, whereas in v-src transformed 3Y1 cells, the early growth response protein-1 (Egr-1) was found to regulate its expression (12) . Collectively, these results suggest that members of the Sp and Egr transcription factor families impact expression of cathepsin L. Because Sp1/Sp3 are present in the granulosa cells (15, 16) , and Egr-1 is induced in the granulosa cells of preovulatory follicles after the LH surge (17, 18) , these factors as well as PR are potential regulators of cathepsin L in ovary. Using transient transfections and EMSAs, our studies document that three Sp1/Sp3 binding sites with one overlapping Egr-1 binding site and a cAMP response element-binding protein (CREB) site within Ϫ244/ ϩ33 bp of promoter region are critical for transactivation of cathepsin L in ovarian granulosa cells. This contrasts with the previous studies in Sertoli cells in which Sp3 and the proximal GC box comprise the basal regulatory element (11) . In situ hybridization analyses indicate further that cathepsin L is expressed in the granulosa cells of growing and ovulating follicles as well as in atretic follicles. 
Materials and Methods Reagents

In situ hybridization
In situ hybridization was performed as described previously by Wilkensen (20) and as previously shown in our laboratory (21) . The riboprobe in vitro transcription systems kit (Promega Corp.) was used to make [S 35 ]uridine 5Ј-triphosphate-labeled antisense and sense probes from the mouse and rat cathepsin L cDNA. The cDNA probes for mouse (6) and rat cathepsin L were generated by RT-PCR amplification and thymidine/adenine cloning (Invitrogen) and verified by sequencing and BLAST analyses (NCBI, Bethesda, MD). Ovaries were fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned at 7 m onto Fisher Superfrost Plus microscope slides (Fisher Scientific, Pittsburgh, PA). Tissue sections were rehydrated, treated with 20 g/ml proteinase K and 0.1 m triethanolamine/acetic anhydride, dehydrated, and incubated with radiolabeled riboprobe overnight at 55 C. The next day slides were washed at high stringency, dried, and exposed to X-OMAT film (Kodak, Rochester, NY) overnight to determine the specificity and intensity of the probe. Slides were dipped in photographic NTB-2 emulsion, exposed at 4 C for an appropriate length of time, developed with D-19 developer and fixer (Kodak), and stained with hematoxylin. Tissue histology was observed by light-field illumination, and dark-field illumination was used to visualize the regions of hybridization.
Cathepsin L promoter deletion and mutation constructs
Cloning of the rat cathepsin L promoter in pGL2 luciferase reporter plasmid and generation of deletion constructs has been described previously (11) . The original construct used contains 2069 bp upstream and 33 bp downstream of the transcription start site of the cathepsin L promoter (AF025476), whereas the deletion construct contains Ϫ244/ ϩ33 region of the proximal promoter.
Site-specific mutations in the cathepsin L promoter were generated using the Gene Editor Site-Directed Mutagenesis Kit from Promega Corp. Oligonucleotides with site-specific mutations at the critical nucleotides necessary for transcription factor binding to the GC boxes [Sp1 (A), (B), and (C)] and the CREB site used for creating mutants are listed in Table 1 . Constructs that contain two transcription factor-binding site mutations were made using a single oligo that contained both the mutations. For generating constructs with three or four mutations, two 
Granulosa cell culture and transfections
Granulosa cells were harvested by needle puncture from immature rats (d 26) or from immature rats treated with E (1.5 mg E/ 0.2 ml in propylene glycol) on d 23-25 of age as described previously (22, 23) . Briefly, cells were cultured in 12-well culture plates at a density of 0.5 ϫ 10 6 cells per 1.5 ml in 1% serum containing medium (DMEM:F12 containing penicillin and streptomycin). Two hours after plating, cells were transiently transfected with 500 ng of the respective constructs with Fugene 6 (Roche Molecular Biochemicals) overnight. On the next day, cells were washed and cultured in fresh, serum-free medium containing FSH (50 ng/ml), forskolin (Fo; 10 m), PMA (20 nm), or both and harvested after 4 h with lysis buffer [0.2 m Tris (pH 8.0) containing 0.1% Triton X-100]. Fo and PMA have previously been used to mimic the effects of the LH surge for optimal induction of COX-2 and PR in cultured rat granulosa cells (15, 24) . The protein concentrations were determined by mini-Bradford assay (Bio-Rad Laboratories, Inc.). Luciferase activity in the extracts was analyzed according to a standard protocol (25) . In brief, a 40-l aliquot of the cell lysate was mixed automatically with 100 l luciferase assay reagent [ Transfection of empty pGL2 vector in granulosa cells showed basal values that were less than unstimulated wild-type pGL2 Ϫ2080/ϩ33 construct. The inducibility of pGL2 by Fo/PMA was never more than 1.5-fold in each experiment. Transfections of MCF-7 human breast cancer cells were carried out using a protocol similar to that adopted for granulosa cells (15) . MCF-7 cells (3 ϫ 10 5 ) were cultured in six-well culture plates with DMEM-F12 containing 1% serum and transfected with various luciferase constructs (1 g) using Fugene 6 overnight. On the next day, Fo and PMA treatment were carried out in serum-free medium.
Transfections of Drosophila SL 2 cells were also carried out using Fugene 6 (15) . SL2 cells (8 ϫ 10 5 ) were cultured in Schneider medium containing 10% fetal bovine serum at 25 C in six-well culture plates. On the next day, the cells were transfected with 1 g of reporter plasmid (Ϫ244/ϩ30 and the Sp1 mutant constructs) with increasing concentrations of pPac-Sp1 expression vector (0 and 1000 ng) adjusted by the addition of pPac vector to equalize the total DNA transfected. After 24 h of transfection, the cells were harvested and assayed for luciferase ac-
Spatiotemporal expression of cathepsin L in the mouse and rat ovary. A, In situ hybridization analyses of cathepsin L in ovarian sections from immature mice as well as from PMSGprimed mice that were treated with hCG to stimulate follicular growth and luteinization, respectively. Using a probe generated to mouse cathepsin, cathepsin L mRNA was detected in the granulosa cells of growing and ovulating follicles. B, In situ hybridization analysis of cathepsin L expression in ovarian sections of PMSG-hCG primed rats as well as in hypophysectomized (H; Hypox) rats treated with estrogen and FSH (HEF) followed by hCG (HEF, hCG) using a rat cathepsin L probe. In these ovaries, cathepsin L message was observed not only in the granulosa cells of preovulatory follicles but also in granulosa cell and theca of follicles stimulated by hCG for 2 and 8 h, respectively. An, Antral follicle; S An, small antral follicle; Ov, ovulatory follicle; Cl, corpus luteum; At, atretic follicle; LF, luteinizing follicle; PO, preovulatory. 
EMSA
Oligonucleotides to the Sp1 sites (A), (B), and (C), the CREB site, and their respective mutants (Table 1) were annealed, labeled, and used in EMSAs as described previously (25) . P 32 -labeled oligonucleotides were incubated with whole-cell extracts (WCEs) prepared from the granulosa cells of hypophysectomized (H) rats treated sequentially with E, FSH (F), and human chorionic gonadotropin (hCG) (HEF, hCG) for 4 h as described previously (25) . After incubation on ice for 30 min, the binding reactions were subjected to nondenaturing electrophoresis (0.5% Trisborate EDTA) at 150 V and autoradiographed after drying the gel. Where indicated, specific antibodies against Sp1, Sp3, Egr-1, CREB, and phosho-CREB were added to the reactions for 30 min on ice before the addition of the labeled probe.
Statistics
The values are represented as mean Ϯ sd for at least three different experiments. The data were analyzed by ANOVA followed by the Neuman-Keuls test to identify significant differences in the group using Graphpad Prism software (San Diego, CA), and a P value less than 0.05 was considered significant.
Results
Expression of cathepsin L
Previous studies showed that cathepsin L is expressed in the granulosa cells of small follicles present in ovaries of pregnant mare's serum gonadotropin (PMSG)-primed mice and was increased after 12 h of hCG treatment (6) . Herein, we have compared the expression of cathepsin L in the mouse ovary with that in the rat ovary. In the immature mouse, cathepsin L is expressed in the granulosa cells of small growing follicles as well as in the granulosa cells of preovulatory follicles of PMSG-treated mice (Fig. 1A) . The amount of cathepsin L increased after stimulation with hCG and with intense staining observed in ovulating follicles (Fig.  1A, 12 and 16 h after hCG) . The spatiotemporal expression of cathepsin L in the ovaries of intact immature rats treated with PMSG and hCG as well as in hypophysectomized (H) rats primed with E (HE), FSH (F; HEF), and hCG (HEF-hCG) was similar to, but also distinct from, that observed in the mouse. Cathepsin L message was detected in the granulosa cells of small follicles present in PMSG-treated rats but was expressed most dramatically in antral follicles 2 h after stimulation with hCG (Fig. 1B) . Unlike the mouse, cathepsin L was induced in the thecal and interstitial compartments of the PMSG-primed rat ovary 8 -12 h after hCG treatment. In these same follicles, the expression of cathepsin L in granulosa cells was less. In the H rat ovary, cathepsin L was expressed in the granulosa cells of some but not all small follicles, and those positive for cathepsin L exhibited signs of atresia (Fig. 1B, hypox, 5ϫ and 20ϫ) . Cathepsin L was also induced in granulosa cells but not in theca cells of preovulatory follicles after hCG stimulation, with the most dramatic Fig. 1B; HEF, hCG, 8 h) . That cathepsin L is detected in the granulosa cells of follicles at many stages of development suggests that the pituitary gonadotropins as well as other factors impact its expression in the ovary. That cathepsin L might be expressed in atretic follicles also indicates that diverse mechanisms impact expression of this gene in the ovary of the mouse and the rat.
Characterization of cathepsin L promoter
The rat cathepsin L promoter was recently cloned, and sequence analysis by BLAST search revealed extensive homology (92%) with the mouse promoter (Fig. 2) . Considering the sequence similarity between these two species, we analyzed the rat cathepsin L promoter to understand the transcription factors that regulate the expression of cathepsin L in rat granulosa cells.
Transactivation of rat cathepsin L promoter.
To determine cathepsin L promoter activity in rat granulosa cells, two rat cathepsin L promoter fragments (Ϫ2080/ϩ33 and Ϫ 244/ ϩ33 bp) ligated to the luciferase reporter gene were analyzed by transient transfection assays. Immature granulosa cells were harvested and cultured overnight in defined medium, transfected, and stimulated with Fo (10 m) to increase cAMP, PMA (20 nm) as a substitute for diacylglycerol, or Fo and PMA that mimic LH action as described in Materials and Methods. Fo alone induced a 6-fold increase in activity of the Ϫ2080/ϩ33-luciferase construct ( Fig. 3 ; ***, P Ͻ 0.001) whereas PMA was less effective (*, P Ͻ 0.05). When both Fo and PMA were added, luciferase activity increased 8-to 10-fold (***, P Ͻ 0.001), demonstrating an additive effect of PMA on Fo inducibility of the promoter (Fig. 3) . FSH activated cathepsin L promoter-reporter constructs as well as Fo (data not shown), and addition of H-89 reduced the Fo/PMA inducibility of the promoter suggesting the involvement of phosphorylation mechanisms in promoter activation (data not shown). Expression of the 5Ј deletion construct (Ϫ244/ ϩ33) containing the proximal promoter region was greater than that of the longer construct (Ϫ2080/ϩ33; ***, P Ͻ 0.001) but showed similar responses to Fo and PMA (***, P Ͻ 0.001; Fig. 3 ). Previous studies by Charron et al. (13) in which rat Sertoli cells were transfected with these same constructs also showed that the shorter promoter construct exhibited high basal activity, suggesting that the regions upstream of Ϫ244 bp repress transactivation of the promoter. To focus on regions necessary for induction for cathepsin L, subsequent analyses were done with the Ϫ244/ϩ33 cathepsin L reporter construct.
Functional analysis of the rat cathepsin promoter.
To assess the functional activity of specific cathepsin L promoter regions, potential transcription factor-binding elements within the Ϫ244/ϩ33-bp region of the promoter were identified by a computer-based search (TFsearch, Tokyo, Japan). This approach did not reveal any consensus PR response elements but did identify three GC-rich putative Sp1 binding sites designated (A), (B), and (C) [A, (Ϫ105/Ϫ94) CCGC-CCCGAG; B and C, TGACGGGGCGGGGGCGGGCC (Ϫ77/ Ϫ66; Ϫ69/Ϫ60)] with an overlapping Egr-1 site at B and C (Ϫ77/Ϫ60); a CREB site [CGGCGTCACG (Ϫ134/Ϫ124); and a CCAAT motif (CAGCCAATGACGG (Ϫ87/Ϫ74)] (Fig. 4A) . To analyze these binding sites, EMSAs were performed with WCEs prepared from granulosa cells (HEF, hCG 4 h) and In this and subsequent figures, the schematic represents the putative functional elements in rat cathepsin L promoter that are being analyzed. [P Ͻ 0.05, control pGL2 basic vs. control pGL2 Ϫ2080/ ϩ33 cathepsin L; P Ͻ 0.001, pGL2 basic vs. pGL2 Ϫ244/ϩ33 control and pGL2 Ϫ2080/ϩ33 control vs. pGL2 Ϫ244/ϩ33 control (not shown in figure) . pGL2 Ϫ2080/ϩ33; *, P Ͻ 0.05 control vs. PMA; ***, P Ͻ 0.001 for comparisons of all other treatments to each other within this group. pGL2 Ϫ244/ϩ33; **, P Ͻ 0.01 PMA vs. Fo; ***, P Ͻ 0.001 for comparisons of all other treatments to each other within this group.] specific oligonucleotides to the transcription factor motifs. When the CREB site was used as a labeled probe, two major protein/DNA protein complexes (I and II) were observed (Fig. 4A) . Competition with a 100-fold excess of wild-type cold competitor DNA prevented the complex formation with the labeled probe, whereas a probe with a mutated CREB site failed to compete. The upper band (complex I) supershifted with CREB antibody identifying CREB as one factor binding to the rat cathepsin L promoter (Fig. 4A) . No detectable supershift was observed with phospho-CREB antibody, and the identity of the other protein/DNA complex is not yet known and may represent a nonspecific component as observed in CRE of other promoters (26) .
When the Sp1 (A) site was used as a probe, two major protein/DNA complexes (I and II) were observed. Competition with the excess wild-type cold competitor prevented the complex formation, whereas Sp1(A)-specific mutant failed to compete (Fig. 4B) . The upper band (I) supershifted in part after the addition of an Sp1 antibody, whereas the lower band (II) was reduced with an Sp3 antibody. When   FIG. 4 . CREB and Sp1/Sp3 bind to the proximal region of the cathepsin L promoter. WCEs were prepared from granulosa cells obtained from immature hypophysectomized treated with E, FSH, and hCG for 2 h (HEF, hCG 2 h). EMSAs were carried out using 3 g of protein and labeled (A) CREB, (B) Sp1 (A) and Sp1 (B and C) oligonucleotide as described in Materials and Methods. Wherever indicated, the extracts were preincubated with 100-fold excess self-cold competitor or mutant probe or 1 g of antibody before the addition of labeled oligonucleotide [CREB* or Sp1(A)* or Sp1(B and C)*]. Protein/DNA complexes were resolved by PAGE in 0.5 ϫ Tris-borate EDTA and exposed to autoradiographic film. The complexes formed are indicated by arrows, and the supershifted complexes are depicted by brackets. The EMSAs are representative of three separate experiments. The asterisk (*) denotes the labeled probe used in EMSAs.
both antibodies were used, complexes I and II were shifted, indicating both Sp1 and Sp3 bind to Sp1 (A) site (Fig. 4B) . The Sp1 (B and C) site contains two putative Sp1/Sp3 sites that overlap an Egr-1 binding site (Fig. 2) . When this region was used as a probe, three protein/DNA complexes were observed, and these were competed with excess cold competitor DNA (Fig. 4B ). Supershift analyses with the Sp1 and Sp3 antibodies documented that bands I and II contained these factors, whereas band III shifted with an Egr-1 antibody. When mutants of site (B) alone, site (C) alone, or sites (B and C) were used as cold competitor DNA, only the double mutant failed to compete for complex formation (Fig. 4B) . When the putative CCAAT motif was used as a labeled probe, no major protein/DNA complex could be detected (data not shown).
Transfection assays with wild-type and site-specific mutants of the cathepsin L promoter were done to determine the relative function of each site. Mutation of the CREB site alone did not alter the inducibility by Fo/PMA (Fig. 5A) . Mutation of Sp1 (A), Sp1 (B), and Sp1 (C) did not alter promoter activity. Double mutants of CREB and Sp1 A or Sp1 B and Sp1 C also failed to modify promoter inducibility (Fig. 5B) . However, mutation of all three Sp1 (A, B, and C) sites significantly reduced basal and Fo/PMA inducibility (***, P Ͻ 0.001) of the promoter (Fig. 5B) . Introduction of a CREB mutation into Sp1/Sp3 triple mutant further reduced the activity of the promoter (***, P Ͻ 0.001; Fig. 5B ). These results indicate that Sp1 binding to the promoter at multiple sites is critical for transactivation of the promoter and that CREB synergistically interacts with the Sp1 to augment the Fo/ PMA response.
Transfection analysis in SL2 cells and MCF-7 cells
The importance of Sp1 and CREB binding in cathepsin L promoter was also assessed in MCF-7 cells that express endogenous Sp1/Sp3 and cathepsin L as well as in Drosophila SL2 cells that lack these Sp proteins (27) . MCF-7 cells were transfected overnight in a defined medium with 1% serum and stimulated with agonist for 4 h the next day. In transfected MCF-7 cells, the relative activity and inducibility of the various cathepsin L promoter-reporter constructs by Fo/ PMA was similar to that observed in granulosa cells. The intact proximal promoter as well as single mutants of the individual Sp1 sites or the CREB site exhibited robust responses to Fo/PMA (Fig. 6A) . Likewise, cathepsin L promoter constructs containing two mutant Sp1 sites did not alter the functional activity of the promoter construct. Mutation of all the Sp1 sites and the CREB site reduced the activity of construct significantly (***, P Ͻ 0.001; Fig. 6A ).
In Drosophila SL2 cells, the wild-type or mutant constructs were cotransfected with increasing concentrations (0 and 1000 ng) of an Sp1 expression plasmid. Little or no luciferase activity was observed when the various cathepsin L promoter-reporter constructs were transfected alone (Fig. 6B) . Coexpression with Sp1 increased luciferase activity dramatically in the wild-type construct. Double and triple mutations of Sp1 sites in the cathepsin L promoter caused a progressive decrease in reporter activity (***, P Ͻ 0.001; Fig. 6B ). Mutation at the three Sp1 sites along with the CREB site further reduced the activity of the promoter (***, P Ͻ 0.001) but did not completely block the response, in contrast to the results in mammalian cells. These results confirm that endogenous as well as exogenous Sp1 is critical for transactivation of cathepsin L promoter in mammalian and insect cells, respectively (Fig. 7) .
Discussion
Cathepsin L is a cysteine protease expressed in many endocrine and nonendocrine tissues and cell types (2, 11, 13) , including the testis where it is expressed in Sertoli cells in a manner that is tightly coupled to specific stages of spermatogenesis that occurs along seminiferous epithelium (11) . Specifically, cathepsin L transcripts are expressed at high levels in mature Sertoli cells in tubules associated at stages VI-VIII and at low or undetectable levels at all other stages (11) . Herein, we show that cathepsin L is also expressed and hormonally regulated in granulosa cells as well as theca cells of the rodent ovary. Specifically, cathepsin L is expressed in the granulosa cells of follicles at several stages of development with greater levels of message observed in ovulatory follicles of mouse and rat (Fig. 1) . The latter induction is dependent on LH and, at least in part, on LH induction of PR (6) . The factors controlling expression of the cathepsin L gene in small follicles of the mouse and rat are less clear. However, the levels of cathepsin L message were not markedly increased by E or FSH, two factors that stimulate preovulatory follicular growth. In the rat ovary, cathepsin L message was abundant in theca cells of ovulatory follicles as well as in small follicles that exhibited signs of atresia (pycnotic nuclei; Fig. 1B ). Because cathepsin L is known to be expressed in macrophages (28) , this may account for some of the cathepsin L expression in these follicles. Although the precise function of cathepsin L is not yet known, the expression of the endogenous gene in the granulosa cells of the mouse and rat occurs in follicles at several different stages of development, indicating that this protease may exert different functions in small vs. ovulatory follicles. For example, in ovulatory follicles cathepsin L may be secreted and hence may be more important as a factor in remodeling the extracellular matrix that is critical for ovulation. It is also possible that cathepsin L acts as a critical intracellular lysosomal enzyme in the granulosa cells of atretic follicles. Finally, cathepsin L likely acts in concert with other proteases at these defined times of granulosa cell differentiation.
The specific factors that regulate the transactivation of the cathepsin L gene in granulosa cells at different stages of follicular growth have not been previously defined. Herein, we have analyzed specific regulatory elements within the rat cathepsin L promoter that confer inducibility by Fo and PMA, agonists that mimic the ovulatory LH signaling cascade (15, 24) . We document the presence and functional relevance of a CRE that binds CREB as well as three Sp1/Sp3 binding sites, one of which also binds Egr-1. These sites that confer transactivation in granulosa cells are similar but also distinct from those documented for expression in other cells, including Sertoli cells (13), 3Y1 and 3T3 cells (2) . As with Sertoli cells, a proximal GC-rich region binds Sp3. In contrast to Sertoli cells, this site also binds Sp1 and Egr-1 present in WCE prepared from granulosa cells of preovulatory follicles exposed to hCG for 2-4 h. In addition, another Sp1/Sp3 site and a CREB binding site all contribute to Fo/PMA activation in granulosa cells. Because mutation of the CREB site alone did not reduce the responses to agonist stimulation, the results suggest that CREB and its interacting partner CREBbinding protein are not the only downstream factors regulated by phosphorylation that impact the cathepsin L promoter. Although Sp1/Sp3 have been reported to be phosphorylated in other systems (29) , phosphorylation of Sp1 in granulosa cells has not yet been documented. Our results show that Egr-1, which is induced by hCG administration in the granulosa cells of preovulatory follicles (18) , binds to this GC-rich promoter region that is highly conserved between rat and mouse and may enhance expression in preovulatory follicles after hCG. Although binding competition between Sp1 and Egr-1 is common in GC-rich elements that exhibit overlapping Sp1 and Egr-1 binding motif (18, 30) , this site in cathepsin L gene appears to bind both in a noncompetitive manner. Similar regions can also be identified in the human promoter but at more distal regions (Fig. 2) . A computerbased search indicated that a functional CCAAT site was present; however, no transcription factor binding to this site was observed.
Although cathepsin L mRNA expression is reduced in the granulosa cells of hCG-stimulated preovulatory follicles of PRKO mice (6) , the role of PR in the regulated expression of cathepsin L is unclear. No consensus PR response elements in the proximal promoter region were identified by computer-based searches, and treatment of cells with the PR agonist R-5020 did not have any effect on basal or inducible expression of the promoter by Fo/PMA. Furthermore, coexpression of PR-A (isoform of PR) (at 5 and 10 ng) with the cathepsin L promoter-reporter constructs did not alter transcriptional activity of the cathepsin L promoter but did activate a PRresponsive GRE promoter-reporter construct in the absence or presence of Fo and PMA (data not shown). Thus, PR does not appear to be interacting with the Sp1/Sp3 or CREB sites (31, 32) but may act at more distal sites within the cathepsin L promoter in vivo. Alternatively, PR may act by regulating the expression of other factors that impact cathepsin L activation. The importance of the GC-rich regions for the transactivation of the cathepsin L promoter allows us to add this gene to a growing number of genes in which GC boxes impact activation, including PR, ADAMTS-1, Sgk, Egr-1, p21CIP, StAR, and P450 scc (15, 16, 18, (33) (34) (35) (36) . Transactivation of the PR promoter, in particular, is dependent on a single critical Sp1/Sp3 binding site within its proximal region (15) that maps to a hypersensitive site (37) . Thus, in the granulosa cells of ovulating follicles, Sp1/Sp3 and associated coregulatory factors appear to constitute a critical transcriptional regulatory complex (Fig. 7) .
